4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001567619-21-019403
Director sold 13,354 shares at $19.50 ($260,403)
From the SEC's structured data for this filing
Trades in this filing
Fust Matthew K · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-11-04 | Sale : show line 1 in the form | −13,354 | $19.50 | $260,403 | 31,500 | D |
| Open-market sales · 13,354 sh · avg $19.50 · $260,403 | ||||||
Loading xslF345X03/doc1.xml…